Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

TRIAD compositions with neuroprotective efficacy reported by Quebec researchers

Jan. 3, 2001

Pharmacokinetics of Co-102862 investigated in animals using new HPLC method

Jan. 3, 2001

Recent patent covers Lilly's new subtype-selective metabotropic glutamate receptor antagonists

Jan. 2, 2001

Zeldox status in Europe updated by Pfizer

Jan. 2, 2001

DU-127090 will be codeveloped by Lundbeck and Solvay for schizophrenia

Jan. 2, 2001

Avanir begins late-stage clinical trials with new drug for neurological disorders

Jan. 2, 2001

Effects of CGP-3466 investigated in models of Parkinson's disease

Jan. 2, 2001

Neurocrine Biosciences' CRF1 and CRF antagonists move towards clinical evaluation

Dec. 29, 2000

Vernalis expands frovatriptan collaboration with Elan; company to buy out royalties from SB

Dec. 29, 2000

Arena's CART-derived 5-HT2A receptor inverse agonists protected by several patents

Dec. 29, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...